Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings
Uwe May, Quirin Werthner, Harald Weigmann, Cosima Bauer · 2025
Read Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings by Uwe May, Quirin Werthner, Harald Weigmann, Cosima Bauer (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12745287.txt.
Description
Uwe May and three co-authors study how rules shape care for erectile dysfunction in this two thousand twenty-five paper. Drugs for the condition, called PDE-5 inhibitors, are sold under different rules across Europe. Some countries allow over-the-counter sales, others need a pharmacist or a doctor's prescription. The team surveyed ten thousand men in four countries. A standard questionnaire identified men with the condition.
Users of the drugs were more common where access was looser. Across all countries, pharmacy buyers were still told to see a doctor. Black market buying stayed minimal in every setting. The survey shows regulation shapes who gets treated, without driving buyers underground. Policy makers weighing wider access to these drugs are the audience.
Catalog record
| CREATOR | Uwe May, Quirin Werthner, Harald Weigmann, Cosima Bauer |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |